Cadrenal Therapeutics Inc... (CVKD)

17.43

-1.57 (-8.26%)

At close: Mar 03, 2025, 3:59 PM

17.40

-0.17%

After-hours: Mar 03, 2025, 04:00 PM EST

Cadrenal Therapeutics Common Stock Cash Flow Statement

Table Mode

Year	FY23	FY22
Net Income	-8.36M	-6.71M
Depreciation & Amortization	1.98K	1.27K
Stock-Based Compensation	710.38K	n/a
Other Working Capital	381.89K	202.84K
Other Non-Cash Items	3.97M	4.5M
Deferred Income Tax	n/a	n/a
Change in Working Capital	144.31K	607.74K
Operating Cash Flow	-3.53M	-1.2M
Capital Expenditures	-3.25K	n/a
Acquisitions	n/a	n/a
Purchase of Investments	n/a	-2.28K
Sales Maturities Of Investments	n/a	n/a
Other Investing Acitivies	n/a	n/a
Investing Cash Flow	-3.25K	-2.28K
Debt Repayment	-250K	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	250K	n/a
Financial Cash Flow	11.9M	1.24M
Net Cash Flow	8.37M	32.59K
Free Cash Flow	-3.53M	-1.2M